IMVAQ Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- September 29, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $15,000,000
Company Info
- Company Description
- Imvaq Therapeutics is an innovative cancer immunotherapy company.
- Market
- Cancer Immunotherapy
- Location
- New York, NY, USA
- Coinvestors
- Hanne Capital